Company / Cash & Equivalents
NATURAL HEALTH TRENDS CORP Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$6.8M
FY2025
5-year range
$6.8M / $83.8M
FY2021-FY2025
Trend
-49.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has declined for 8 consecutive years, from $135M in FY2017 to $7M in FY2025.
Based on SEC 10-K filings.
$7M in FY2025 with a 5-year CAGR of -40.6%.
Declined from $56M to $7M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -53.9%
- 5-Year CAGR
- -40.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- NATURAL HEALTH TRENDS CORP's cash & equivalents has declined for 8 consecutive years.
- 5-year CAGR of -40.6%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 49.7% year-over-year.
- Peak cash & equivalents was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.88 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.8M | -49.7% |
| FY2024 | $13.5M | -75.9% |
| FY2023 | $56.2M | -19.4% |
| FY2022 | $69.7M | -16.9% |
| FY2021 | $83.8M | -9.2% |
| FY2020 | $92.4M | -3.8% |
| FY2019 | $96.0M | -27.6% |
| FY2018 | $132.7M | -2.0% |
| FY2017 | $135.3M | +201.9% |
| FY2016 | $44.8M | +208.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026